Understanding Irinotecan: Dosing, Toxicity, and Innovations

This chapter delves into the pharmacology of Irinotecan, highlighting dosing variations due to enzyme-inducing anti-epileptic drugs and addressing the major side effect of diarrhea. It also discusses recent advancements, including the liposomal formulation's FDA approval and the significance of pharmacogenetic considerations for personalized chemotherapy treatment.